What Colour Is Visceral Fat? Facts and Health Risks

Visceral fat is yellowish-white in colour, a pale, lobulated tissue found deep within the abdominal cavity surrounding vital organs such as the liver, pancreas and kidneys. Unlike subcutaneous fat, which you can pinch beneath the skin, visceral fat is invisible to the naked eye in everyday life and is only seen during surgery, medical imaging or post-mortem examination. Its colour, metabolic activity and location make it clinically distinct, and understanding what it looks like, how it differs from other fat, and how to measure and reduce it is important for managing long-term metabolic health.

What colour is visceral fat and how does it look inside the body?

Visceral fat is yellowish-white in colour, appearing as a dense, lobulated mass of pale yellow tissue around the abdominal organs, visible only during surgery, imaging or post-mortem examination.

Visceral fat is yellowish-white in colour, similar in appearance to other body fat, but it is found deep within the abdominal cavity, packed around organs such as the liver, pancreas, kidneys and intestines.^[11] Unlike the fat visible beneath the skin, visceral fat is not accessible to the eye or touch during everyday life. It is only visible during surgical procedures, medical imaging or post-mortem examination, where it appears as a dense, lobulated mass of pale yellow tissue nestled between and around the abdominal organs.

The yellow hue of visceral fat comes from the presence of carotenoids and lipid-soluble pigments stored within fat cells (adipocytes). All adipose tissue shares this basic colouring, but visceral fat is metabolically distinct from subcutaneous fat. It is more densely vascularised and contains a higher proportion of inflammatory immune cells, which contributes to its association with metabolic disease.^[12][15]

On computed tomography (CT), fat appears as a region of characteristically low attenuation (appearing dark) within the abdominal cavity. On magnetic resonance imaging (MRI), fat produces a distinctive bright signal on standard sequences, and specialist sequences can be used to confirm its composition. Radiologists can differentiate visceral fat from subcutaneous fat by its anatomical location, specifically its position inside the peritoneal cavity rather than beneath the skin. This distinction matters clinically because the quantity of visceral fat, rather than overall body weight, is more closely linked to conditions such as type 2 diabetes, cardiovascular disease and metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease), according to NHS and NICE guidance on obesity management.

How is visceral fat different from the fat you can pinch?

Visceral fat lies deep inside the abdominal cavity and cannot be felt from outside, unlike subcutaneous fat; it is metabolically more active, releasing inflammatory cytokines into the portal circulation and carrying greater metabolic risk.

Visceral fat differs fundamentally from subcutaneous fat in its location, metabolic behaviour and health implications. Subcutaneous fat sits directly beneath the skin and is the fat you can physically pinch, particularly around the abdomen, thighs and upper arms. Visceral fat, by contrast, lies deep inside the abdominal cavity, surrounding vital organs, and cannot be felt from the outside.

Metabolically, visceral fat is considerably more active than subcutaneous fat. It releases fatty acids, inflammatory cytokines and hormones directly into the portal circulation, which drains into the liver. This proximity to the liver means that excess visceral fat can contribute to insulin resistance, raised triglycerides and low-grade systemic inflammation. Subcutaneous fat, while not entirely benign in large quantities, does not carry the same degree of metabolic risk.

The two types of fat also respond differently to lifestyle interventions. Evidence suggests that visceral fat can be more responsive to aerobic exercise and dietary changes than subcutaneous fat, though individual responses vary.^[8][9] This is clinically relevant because a person may appear to have a modest body mass index (BMI) yet still carry a significant burden of visceral fat, a pattern sometimes described in research as being metabolically obese at a normal weight (this is a descriptive research term rather than a formal clinical diagnosis).

It is also worth noting that body shape can offer indirect clues. A predominantly central or apple-shaped distribution of weight, with fat accumulating around the waist rather than the hips and thighs, is more likely to reflect higher visceral fat stores. NHS guidance highlights waist circumference as a practical proxy measure for this reason.

Can you tell how much visceral fat you have without a scan?

Waist circumference is the most practical indirect measure of visceral fat; NICE recommends thresholds of 94 cm or above in men and 80 cm or above in women as indicating increased metabolic risk.

Waist circumference is the most practical and widely recommended indirect measure of visceral fat in clinical settings, and NICE guidance on obesity includes it as a key assessment tool alongside BMI.^[2] NHS guidance describes two levels of risk based on waist circumference for white European adults: an increased risk threshold of 94 cm (37 inches) or above in men and 80 cm (31.5 inches) or above in women, and a substantially increased risk threshold of 102 cm (40 inches) or above in men and 88 cm (35 inches) or above in women. These thresholds are lower for people of South Asian, Chinese, Japanese and other Asian backgrounds, reflecting differences in body composition and metabolic risk at a given waist size; your GP can advise on the appropriate thresholds for your background.^[2][17]

To measure your waist correctly, use a tape measure placed midway between the bottom of your lowest rib and the top of your hip bone (iliac crest), usually around the level of your navel. The tape should be snug but not compressing the skin, and the measurement taken after a gentle breath out.

Waist-to-height ratio is another simple measure that some researchers consider informative. A general guide is that a healthy waist circumference should be less than half a person's height, though this is a population-level indicator rather than a diagnostic threshold.^[6][5]

BMI alone is a poor indicator of visceral fat. Two people with identical BMIs can have very different distributions of fat, and BMI does not distinguish between fat mass and lean muscle mass. For this reason, clinicians use waist circumference alongside BMI to build a more complete picture of metabolic risk.

CT and MRI scanning can quantify visceral adipose tissue with precision and are used as reference methods in research settings. Dual-energy X-ray absorptiometry (DEXA) scanning is also used in some clinical and research contexts. However, these investigations are not generally offered on the NHS solely to measure visceral fat, and availability may vary locally. If you are concerned about your metabolic risk, speaking to your GP is the appropriate first step. They can assess your waist circumference, BMI and relevant blood markers, and refer you for further investigation if clinically indicated.

What is the most effective way to reduce visceral fat?

A sustained combination of regular aerobic exercise and a calorie-controlled, nutritionally balanced diet is the most effective approach, with pharmacological options such as semaglutide or tirzepatide available for eligible adults.

A sustained combination of regular aerobic exercise and a calorie-controlled, nutritionally balanced diet is the most effective approach to reducing visceral fat, consistent with NICE guidance on weight management. Visceral fat is particularly responsive to aerobic activity such as brisk walking, cycling, swimming or jogging. Evidence suggests that even modest reductions in overall body weight, in the region of 5 to 10 per cent, can lead to meaningful reductions in visceral fat and associated metabolic risk factors.^[3]

Dietary quality matters alongside overall calorie intake. Reducing consumption of foods high in refined carbohydrates, added sugars and alcohol has been associated with reductions in visceral adiposity. A diet aligned with the NHS Eatwell Guide, rich in vegetables, wholegrains, lean protein and unsaturated fats, supports both weight management and metabolic health. The NHS Better Health programme and NICE guidance both recommend structured behavioural support alongside dietary and physical activity changes for sustained results.

For people with obesity-related health conditions who have not achieved sufficient benefit from lifestyle changes alone, pharmacological treatment may be considered. Medicines such as semaglutide (Wegovy) and tirzepatide (Mounjaro) are MHRA-authorised for chronic weight management in eligible adults.^[18][24] Clinical trial data, including imaging substudies, have indicated reductions in visceral fat with these treatments, though a prescriber will assess whether either medicine is appropriate for an individual's circumstances.^[19] Wegovy is available in doses up to 2.4 mg weekly, with a higher 7.2 mg weekly dose also licensed in the UK; the appropriate dose is determined by individual clinical assessment in line with the UK Summary of Product Characteristics. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a clinician can assess whether a treatment is appropriate for an individual's circumstances.

If you are concerned about your weight or metabolic health, contact your GP in the first instance. They can assess your risk, arrange relevant blood tests and discuss the full range of management options available to you through the NHS.

Frequently Asked Questions